In the complex landscape of pharmaceutical manufacturing, the identification and procurement of key intermediates are fundamental to bringing life-saving drugs to market. Among these crucial compounds is 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, identified by its CAS No. 210963-78-3. This article delves into the significance of this chemical intermediate and its role as a building block in pharmaceutical synthesis.

The Chemical Profile of an Essential Intermediate

4-[(Dimethylamino)iminomethyl]benzoic Acid HCl is recognized for its specific molecular formula, C10H13ClN2O2, and a molecular weight of 228.67542. Typically presented as a white powder, its physical form is conducive to handling and precise integration into chemical reaction sequences. As a derivative of benzoic acid, it possesses a structural framework that is highly valued in organic synthesis, particularly within the pharmaceutical sector.

Role in API Synthesis and Drug Development

The primary application of 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl lies in its function as a pharmaceutical intermediate. It serves as a critical starting material or intermediate step in the multi-stage synthesis of various APIs. Its precise chemical structure allows for targeted reactions, leading to the formation of complex molecules that form the basis of many therapeutic agents. For drug developers, having a consistent and reliable source for this intermediate is paramount to maintaining production schedules and ensuring the quality of their final drug products. Companies seeking to buy this intermediate are looking for purity, availability, and competitive pricing from qualified suppliers.

Procurement Strategies for Pharmaceutical Intermediates

When procuring essential chemical intermediates like 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, pharmaceutical companies often look to established chemical manufacturers and suppliers. Given its origin and availability, China is a significant source for such compounds. Buyers prioritize suppliers who can demonstrate a strong commitment to quality control, provide comprehensive product documentation, and maintain a robust supply chain. Engaging with these suppliers ensures that your procurement process is streamlined and that you receive materials that meet rigorous pharmaceutical standards. We, as a dedicated supplier, are committed to providing this vital intermediate to support your pharmaceutical manufacturing needs.

Conclusion

4-[(Dimethylamino)iminomethyl]benzoic Acid HCl (CAS 210963-78-3) stands as a testament to the critical role that specialized chemical intermediates play in the pharmaceutical industry. Its utility as a building block for APIs underscores the importance of reliable sourcing from experienced manufacturers. For businesses seeking to optimize their supply chain for this key intermediate, diligent research into supplier capabilities and product specifications is essential.